Behavior Modification Wristwatch
A wristwatch including a watch band and a watch body having an octagon shaped perimeter and being red in color and having the word STOP thereon to resemble a stop sign.
Make the Most of Our Site
See this month's Top Inventors and Most Cited Patents.
Stay on top of the latest innovations by subscribing to an RSS feed.
Registered users: Manage your profile.
| Number | Title | Issue Date |
| 7361653 | Pest control agent composition and method of using the same The present invention relates to a composition for noxious organisms-controlling agent having a synergistic effect and a method for using said composition, which comprises, as active ingredients thereof, one or more compounds selected from the phthalamide derivative... | 04/22/2008 |
| 7332511 | Vanilloid receptor ligands and their use in treatments Compounds having the general structure and compositions containing them, for the treatment of acute, inflammatory and neuropathic pain, dental pain, general headache, migraine, cluster headache, mixed-vascular an... | 02/19/2008 |
| 7279582 | Retroviral protease inhibiting compounds A compound of the formula: is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed. ... | 10/09/2007 |
| 7262294 | Photochromatic pyrano-1,3-oxazinonaphthalene derivatives Photochromatic compounds belonging to the groups of chromenes and spiro-pyrans having general formula (I) ... | 08/28/2007 |
| 7166609 | Pyrimidine-4,6-dicarboxylic acid diamides for selectively inhibiting collagenases Pyrimidine-4,6-dicarboxylic acid diamides of the formula I are suitable for selectively inhibiting collagenase (MMP 13). The pyrimidine-4,6-dicarboxylic acid diamides can therefore be used for treating degenerati... | 01/23/2007 |
| 7163748 | Method for making solid, ungelled aminoplast crosslinkers Methods for preparing crosslinking agents that are the ungelled reaction product of (a) at least one aminoplast resin and (b) at least one modifying compound, wherein the crosslinking agents are essentially free of active hydrogen functional groups and have a glass ... | 01/16/2007 |
| 7132455 | Phthalamide derivatives This invention relates to novel phthalamide derivatives of formula (I) wherein R1, R2, R3, R4, and R5 have the meanings given in the... | 11/07/2006 |
| 7053138 | Flame-proofing agents Compounds of formula (I) or (II), wherein R1 is C1–C18alkyl; C5–C12cycloalkyl that is unsubstituted or substituted by one or more C1–C6alkyl groups or C1–C6alk... | 05/30/2006 |
| 6924251 | Substituted benzoylcyclohexandiones The invention relates to novel substituted benzoylcyclohexanediones of the general formula (I), in which m, n, A, R1, R2, R3, R4 and Z are each as defined in the... | 08/02/2005 |
| 6900161 | Azole or triazole derivatives, method for preparing same and use thereof as fungicides The invention concerns novel azole or triazole derivatives of formula (Ia) or (Ib), wherein: X, Ar1, Ar2, Ar3, A, B and R1 are such as defined in the description, the method for preparing same and their use as fungicides. ... | 05/31/2005 |
| 6780856 | Towards increased shelf life for cobalt(III) schiff base complexes The invention relates to methods of stabilizing in an aqueous medium cobalt (III) Schiff base complexes and stabilized cobalt (III) Schiff base compounds therefrom. ... | 08/24/2004 |
| 6777404 | Use of corticotropin releasing factor antagonists and related compositions The present invention relates to compositions and methods of achieving a therapeutic effect including, the treatment or prevention of Syndrome X in an animal, preferably a mammal including a human subject or a companion animal, using a corticotropin releasing factor... | 08/17/2004 |
| 6759402 | Cyclic felbamate derived compounds The present invention relates to novel felbamate derivatives and their use to treat neurological diseases such as epilepsy and to treat tissue damage resulting form ischemic events. The felbamate derivatives are modified to prevent the formation of metabolites that ... | 07/06/2004 |
| 6699898 | Substituted N,N-disubstituted non-fused heterocyclo amino compounds useful for inhibiting cholesteryl ester transfer protein activity The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating... | 03/02/2004 |
| 6673804 | Sulfonamide derivatives A compound of the formula (I) or a pharmacologically acceptable salt, ester or other derivative thereof: ##STR1## R1 is H or NHOH. R2 is H, optionally substituted alkyl, cycloalkyl or a group --AR6. A is an alkylen... | 01/06/2004 |
| 6663972 | Modified aminoplast crosslinkers and powder coating compositions containing such crosslinkers A crosslinking agent having reactive benzoxazine groups is provided. The crosslinking agent is an ungelled reaction product of aminoplast resin, a polyhydric aromatic compound, and at least one compound having active hydrogen groups reactive with aminopla... | 12/16/2003 |
| 6642379 | Benzamide derivatives, insecticides for agricultural and horticultural use and usage thereof Benzamide derivatives represented by the general formula (I): ##STR1## and insecticides for agricultural and horticultural use and usage thereof, wherein Z1 is O or S; R is H, (substituted) alkyl, or alkoxycarbonyl; X is halogeno, cyano, nitro,... | 11/04/2003 |
| 6576628 | 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same The invention relates to inhibitors of matrix metalloproteases, more specifically a 3-aryl-succinamido-hydroxamic acid of formula (I) ##STR1## and its salt, ester and derivative thereof, along with methods of producing a compound of formula (I) and pharma... | 06/10/2003 |
| 6559100 | 2-benzoyl-cyclohexane-1,3-diones Substituted 2-benzoylcyclohexane-1,3-diones of the formula I ##STR1## where: R1 and R2 are each hydrogen, mercapto, nitro, halogen, cyano, thiocyanato, C1 -C6 -alkyl, C1 -C6 -haloalkyl, C1 | 05/06/2003 |
| 6534492 | Uracil substituted phenyl sulfamoyl carboxamides Novel uracil substituted phenyl sulfamoyl carboxamides I ##STR1## and salts thereof, where A=oxygen or sulfur; X1 =H, halogen, C1 -C4 -alkyl; X2 =H, CN, CS--NH2, halogen, C1 -C4 -alkyl, C | 03/18/2003 |
| 6472529 | Retroviral protease inhibiting compounds A compound of the formula: ##STR1## is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.... | 10/29/2002 |
| 6469000 | 1,3-diheterocyclic metalloprotease inhibitors Disclosed are compounds which are inhibitors of metalloproteases having the following structure: ##STR1## where Ar, W, X, Y, Z, R1 and R2 have the meanings described in the specification and optical isomers, diastereomers, and enanti... | 10/22/2002 |
| 6451830 | Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for t... | 09/17/2002 |
| 6448286 | Imino pyrrolidine derivatives useful as nitric oxide synthase inhibitors The current invention discloses useful pharmaceutical compositions containing amidino derivative useful as nitric oxide synthase inhibitors.... | 09/10/2002 |
| 6433124 | Reactive polymers and isocyanate-reactive polymers obtainable therefrom In a compound of the formula I ##STR1## (reactive polymer), L is a, polymer, XY is a reactive radical which is inert toward NCO groups and splits off one or more protective groups Y under acidic, neutral or basic conditions and the radical X bears, after ... | 08/13/2002 |
| 6417353 | Preparing amines Amines are prepared by reacting aldehydes or ketones at elevated temperature under elevated pressure with nitrogen compounds selected from the group of ammonia, primary and secondary amines, and with hydrogen in the presence of a catalyst containing coppe... | 07/09/2002 |
| 6358982 | Heterocyclyl sulphonamide derivatives The present invention relates to the potentiation of glutamate receptor function using certain heterocyclyl sulphonamide derivatives. It also relates to novel heterocyclyl sulphonamide derivatives, to processes for their preparation and to pharmaceutical ... | 03/19/2002 |
| 6358980 | Alkynyl containing hydroxamic acid compounds as matrix metalloproteinase/tace inhibitors Compounds of the formula: ##STR1## useful in the treatment of arthritis, tumor metastasis, tissue ulceration, abnormal wound healing, periodontal disease, bone disease, diabetes (insulin resistance) and HIV infection.... | 03/19/2002 |
| 6316109 | Aminoplast-based crosslinkers and powder coating compositions containing such crosslinkers A crosslinking agent having reactive benzoxazine groups is provided. The crosslinking agent is the ungelled reaction product of a polyhydric aromatic compound and an aminotriazine compound having one or less non-alkylated NH bond per triazine ring. The cr... | 11/13/2001 |
| 6281228 | Heterocyclic inhibitors of microsomal triglyceride transfer protein and method Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof, or prodrug ester... | 08/28/2001 |
| 6271235 | HIV protease inhibitors HIV protease inhibitors, obtainable by chemical synthesis, inhibit or block the biological activity of the HIV protease enzyme, causing the replication of the HIV virus to terminate. These compounds, as well as pharmaceutical compositions that contain the... | 08/07/2001 |
| 6235901 | Oxazoline or oxazine acetoacetate aqueous coating compositions A novel compound having the formula: ##STR1## wherein R is an alkyl group containing 1-5 carbon atoms or an aryl, substituted aryl, substituted or unsubstituted heteroaryl, alkyl-aryl, alkylether-aryl or O; R1 and R2 are hydrogen or ... | 05/22/2001 |
| 6166010 | Azine derivatives The invention relates to the use of azine derivatives, some of which are known, of the formula ##STR1## in which A represents substituted phenyl, or represents in each case optionally substituted naphthyl, pyridyl, thienyl or pyrazolyl; B represents ... | 12/26/2000 |
| 6150532 | Modulators of proteins with phosphotyrosine recognition units The present invention relates to novel protein tyrosine phosphatase modulating compounds having the general structure shown in Formula (A1), to methods for their preparation, to compositions comprising the compounds, to their use for treatment of human an... | 11/21/2000 |
| 6008223 | Therapeutic compounds Compounds of formula I ##STR1## wherein Q1, Q2, Q3, and Q4 have any of the meanings given in the specification, their N-oxides, and their pharmaceutically acceptable salts are nonpeptide antagonists of SP a... | 12/28/1999 |
| 5965577 | Heterocyclic inhibitors of microsomal triglyceride transfer protein and method Novel compounds are provided which are inhibitors of MTP and thus are useful for lowering serum lipids and treating atherosclerosis and related diseases, and have the structure ##STR1## including pharmaceutically acceptable salts thereof, or prodrug ... | 10/12/1999 |
| 5962437 | Lipid analogs for treating viral infections A method of treating viral infections, and in particular HIV-1, hepatitis B virus and herpes viruses, is disclosed. The method comprising administering to a subject in need of such treatment an infection-combating amount of a phospholipid or phospholipid ... | 10/05/1999 |
| 5936124 | Fluoxetine process from benzoylpropionic acid A synthesis of fluoxetine is disclosed. The process begins with a lower alkyl ester of 3-benzoylpropionic acid, which is reduced in the presence of a chiral ligand to produce the corresponding γ-hydroxy ester, and the ester is cleaved. The free acid is t... | 08/10/1999 |
| 5922748 | Indole derivatives as 5-HT agonists Compounds of formula (I) ##STR1## wherein R and R1 are hydrogen, C1-4 alkyl or are linked to form a ring, A is a cycloalkyl or alkyl-cycloalkyl group, n is an integer from 0 to 3, W is an optionally substituted 5-or 6-membered hetero... | 07/13/1999 |
| 5914332 | Retroviral protease inhibiting compounds A compound of the formula: ##STR1## is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.... | 06/22/1999 |